BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 34512645)

  • 1. Activation Phenotype of
    Luo Y; Xue Y; Mao L; Lin Q; Tang G; Song H; Liu W; Tong S; Hou H; Huang M; Ouyang R; Wang F; Sun Z
    Front Immunol; 2021; 12():721013. PubMed ID: 34512645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of HLA-DR on
    Luo Y; Xue Y; Tang G; Lin Q; Song H; Liu W; Yin B; Huang J; Wei W; Mao L; Wang F; Sun Z
    Front Immunol; 2021; 12():761209. PubMed ID: 34858413
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers on patient T cells diagnose active tuberculosis and monitor treatment response.
    Adekambi T; Ibegbu CC; Cagle S; Kalokhe AS; Wang YF; Hu Y; Day CL; Ray SM; Rengarajan J
    J Clin Invest; 2015 May; 125(5):1827-38. PubMed ID: 25822019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte-Related Immunological Indicators for Stratifying
    Luo Y; Xue Y; Tang G; Cai Y; Yuan X; Lin Q; Song H; Liu W; Mao L; Zhou Y; Chen Z; Zhu Y; Liu W; Wu S; Wang F; Sun Z
    Front Immunol; 2021; 12():658843. PubMed ID: 34276653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of prealbumin and tuberculosis-specific antigen/phytohemagglutinin ratio for discriminating active tuberculosis from latent tuberculosis infection.
    Luo Y; Xue Y; Yuan X; Lin Q; Tang G; Mao L; Song H; Wang F; Sun Z
    Int J Clin Pract; 2021 Apr; 75(4):e13831. PubMed ID: 33175465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utility of interferon gamma/tumor necrosis factor alpha FluoroSpot assay in differentiation between active tuberculosis and latent tuberculosis infection: a pilot study.
    Zhang L; Wan S; Zhou Z; Zhang Y; Liu X
    BMC Infect Dis; 2021 Jul; 21(1):651. PubMed ID: 34225667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combination of iron metabolism indexes and tuberculosis-specific antigen/phytohemagglutinin ratio for distinguishing active tuberculosis from latent tuberculosis infection.
    Luo Y; Xue Y; Lin Q; Tang G; Yuan X; Mao L; Song H; Wang F; Sun Z
    Int J Infect Dis; 2020 Aug; 97():190-196. PubMed ID: 32497795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphocyte Non-Specific Function Detection Facilitating the Stratification of
    Luo Y; Xue Y; Cai Y; Lin Q; Tang G; Song H; Liu W; Mao L; Yuan X; Zhou Y; Liu W; Wu S; Sun Z; Wang F
    Front Immunol; 2021; 12():641378. PubMed ID: 33953714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple cytokine responses in discriminating between active tuberculosis and latent tuberculosis infection.
    Wu J; Wang S; Lu C; Shao L; Gao Y; Zhou Z; Huang H; Zhang Y; Zhang W
    Tuberculosis (Edinb); 2017 Jan; 102():68-75. PubMed ID: 28061954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of plasma cytokine biosignature combination and MCP-1 as individual biomarkers for differentiating stages Mycobacterium tuberculosis infection.
    Luo J; Zhang M; Yan B; Li F; Guan S; Chang K; Jiang W; Xu H; Yuan T; Chen M; Deng S
    J Infect; 2019 Apr; 78(4):281-291. PubMed ID: 30528869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The ratio of tuberculosis-specific antigen to phytohemagglutinin in T-SPOT assay in the diagnosis of active tuberculosis].
    Wang T; Tan YJ; Wu SJ; Huang M; Yin BT; Huang J; Wei N; Wei W; Wang F
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Apr; 42(4):262-267. PubMed ID: 30955283
    [No Abstract]   [Full Text] [Related]  

  • 12. Mycobacterium tuberculosis latency-associated antigen Rv1733c SLP improves the accuracy of differential diagnosis of active tuberculosis and latent tuberculosis infection.
    Zhang L; Ma H; Wan S; Zhang Y; Gao M; Liu X
    Chin Med J (Engl); 2022 Jan; 135(1):63-69. PubMed ID: 34802023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cells co-producing Mycobacterium tuberculosis-specific type 1 cytokines for the diagnosis of latent tuberculosis.
    Nemeth J; Winkler HM; Karlhofer F; Selenko-Gebauer N; Graninger W; Winkler S
    Eur Cytokine Netw; 2010 Mar; 21(1):34-9. PubMed ID: 20146988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotypic Changes on Mycobacterium Tuberculosis-Specific CD4 T Cells as Surrogate Markers for Tuberculosis Treatment Efficacy.
    Ahmed MIM; Ntinginya NE; Kibiki G; Mtafya BA; Semvua H; Mpagama S; Mtabho C; Saathoff E; Held K; Loose R; Kroidl I; Chachage M; von Both U; Haule A; Mekota AM; Boeree MJ; Gillespie SH; Hoelscher M; Heinrich N; Geldmacher C
    Front Immunol; 2018; 9():2247. PubMed ID: 30323818
    [No Abstract]   [Full Text] [Related]  

  • 15. Study of CD27 and CCR4 Markers on Specific CD4
    Latorre I; Fernández-Sanmartín MA; Muriel-Moreno B; Villar-Hernández R; Vila S; Souza-Galvão ML; Stojanovic Z; Jiménez-Fuentes MÁ; Centeno C; Ruiz-Manzano J; Millet JP; Molina-Pinargote I; González-Díaz YD; Lacoma A; Luque-Chacón L; Sabriá J; Prat C; Domínguez J
    Front Immunol; 2018; 9():3094. PubMed ID: 30687314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of CD27, CD38, HLA-DR and Ki-67 immune profiles for the characterization of active tuberculosis, latent infection and end of treatment.
    Díaz-Fernández S; Villar-Hernández R; Stojanovic Z; Fernández M; Galvão MLS; Tolosa G; Sánchez-Montalva A; Abad J; Jiménez-Fuentes MÁ; Safont G; Romero I; Sabrià J; Prat C; Domínguez J; Latorre I
    Front Microbiol; 2022; 13():885312. PubMed ID: 35935194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential T cell responses against DosR-associated antigen Rv2028c in BCG-vaccinated populations with tuberculosis infection.
    Zhao HM; Du R; Li CL; Ji P; Li HC; Wu K; Hu Z; Lu SH; Lowrie DB; Fan XY
    J Infect; 2019 Apr; 78(4):275-280. PubMed ID: 30528871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of CD4/CD8+ αβ and Vγ2Vδ2+ T cells in HIV-negative individuals with different Mycobacterium tuberculosis infection statuses.
    Gao Y; Zhang S; Ou Q; Shen L; Wang S; Wu J; Weng X; Chen ZW; Zhang W; Shao L
    Hum Immunol; 2015 Nov; 76(11):801-7. PubMed ID: 26429305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of Blood Routine Examination and T-SPOT.TB Assay for Distinguishing Between Active Tuberculosis and Latent Tuberculosis Infection.
    Luo Y; Tang G; Yuan X; Lin Q; Mao L; Song H; Xue Y; Wu S; Ouyang R; Hou H; Wang F; Sun Z
    Front Cell Infect Microbiol; 2021; 11():575650. PubMed ID: 34277462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of diagnostic algorithm using machine learning for distinguishing between active tuberculosis and latent tuberculosis infection.
    Luo Y; Xue Y; Liu W; Song H; Huang Y; Tang G; Wang F; Wang Q; Cai Y; Sun Z
    BMC Infect Dis; 2022 Dec; 22(1):965. PubMed ID: 36581808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.